Report Summarizes Liver Fibrosis Study Findings from University of California San Diego (UCSD) (The Origin and Fate of Liver Myofibroblasts).

A recent study conducted at the University of California San Diego (UCSD) has examined the development and reversibility of liver fibrosis, a serious health problem worldwide. The study found that liver fibrosis is caused by fibrogenic myofibroblasts that activate in response to chronic toxic or cholestatic injury. However, the regression of liver fibrosis is possible when the underlying cause of injury is removed. The study discusses the molecular mechanisms involved in the activation, apoptosis, and inactivation of myofibroblasts. This research provides valuable insights into potential therapies for liver fibrosis. [Extracted from the article]

Copyright of Gastroenterology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)